May 2026

Hammer Metals reports strong initial drilling results at its Kalman Critical Metals Project, confirming broad zones of copper, gold, molybdenum, and rhenium mineralisation and supporting a resource upgrade ahead of a Scoping Study.

Red Mountain Mining has produced a high-grade 51.8% antimony concentrate from Oaky Creek with excellent 85% recovery, setting the stage for upcoming drilling to define the resource along a 3km mineralised strike in NSW.

Desert Metals has expanded its Tiogo gold anomaly at Tengrela South, Côte d'Ivoire, by over 3km northwards, unveiling a new high-priority target ready for drilling.

MetalsGrove Mining has identified extensive gold anomalous trends spanning 18km at its Zuénoula permit, setting the stage for multiple drill targets as soil sampling and assay results advance.

Vodafone Group Plc’s 2026 Annual Report reveals a transformative year marked by the full consolidation of VodafoneThree UK after a landmark merger, acquisition of Telekom Romania and Skaylink, and a planned controlling stake in Safaricom. The Group achieved strong financial results, increased dividends, and reinforced ESG commitments across Europe and Africa.

Pacific Edge reported a steep 47% revenue drop in FY26 following Medicare coverage loss but secured a draft Medicare policy covering its Cxbladder tests and raised NZ$25.4 million to fuel growth and commercial execution.

Radius Residential Care has syndicated its bank debt, boosting facility limits by NZD 30 million and cutting financing costs by 65 basis points to support its growth plans, including a new care home acquisition and development projects.

TruScreen Group has secured NZ$1.82 million through an oversubscribed placement, underscoring investor confidence amid its global cervical screening expansion. The company also announced a renounceable rights issue and attaching options, both subject to shareholder approval.

EROAD reported flat group revenue of NZD 195.2 million for FY26, driven by strong Australian growth and steady New Zealand performance, offset by a North American decline and a hefty goodwill impairment.

Battery tech, biotech and balance-sheet repair drove the biggest gains this week, while guidance cuts and weak post-halt trading hurt several names. Deal-making and fresh equity funding stayed busy, especially in rare earths, defence and gold.

Big gains in InvestSMART met heavy selling in General Capital and Klevo as investors split between clean balance-sheet stories and names carrying extra uncertainty. Finance stocks were driven by capital returns, raisings, loan growth and a handful of governance risks.

Coal, gold and critical minerals names drove the biggest share moves this week, but strong project news did not always lead to lasting gains. Several stocks jumped on funding, deals and study results, while others gave back early gains as traders locked in profit or worried about dilution.

Imugene, Vitasora and Adherium led a volatile week in healthcare shares, as trial news and software rollouts battled capital raisings, legal issues and weak sentiment in smaller biotech names. Big contracts, takeover steps and record earnings kept the sector busy, but several stocks still fell even after reporting clear operational progress.

Capital moves, contract wins and AI product pushes drove a busy week across small and mid-cap technology stocks. Hydrix, Complii and ClearVue led the board, while investors sold names where early excitement gave way to dilution concerns or softer earnings detail.

Alternative Investment Trust (AIQ) has issued 7.39 million units at A$1.38 each, raising A$10.2 million from wholesale investors without a product disclosure statement. The capital raise aligns with AIQ’s adjusted net tangible asset value and complies with Corporations Act requirements.

Gumtree Australia Markets has refinanced its Commonwealth Bank loan, cutting quarterly repayments and extending the facility to November 2027, freeing up cashflow to support sales growth.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.

1414 Degrees Limited has responded to an ASX price query after its shares jumped from $0.056 to $0.097 in days, confirming no undisclosed information but highlighting progress in aerospace and energy projects.

South Port New Zealand is navigating a significant leadership transition with CEO Nigel Gear stepping down after 8.5 years, replaced by port veteran Derek Nind, while Chair Philip Cory-Wright plans retirement. The company reports strong trading momentum, aiming for a record full year despite geopolitical uncertainties.

SDI Limited has dispatched its Scheme Booklet to shareholders as it moves closer to a $1.40 per share acquisition by a Beijing Guoci subsidiary. The virtual shareholder meeting is set for 22 June 2026 with strong backing from the board and largest shareholder.

Orion Minerals has secured $15.4 million in a placement to accelerate development at its Prieska and Okiep copper projects in South Africa, paving the way for its transition to a copper producer.

Vmoto Limited disclosed it held only one formal board meeting in FY25, relying heavily on circular resolutions, and outlined plans to increase meeting frequency in 2026. The company clarified its trade insurance arrangements and affirmed director independence amid ASX queries.

Mayne Pharma has been awarded $13.27 million in legal costs by the Supreme Court of New South Wales after successfully defending against Cosette Pharmaceuticals’ claims tied to a terminated acquisition deal.

Finico Pty Ltd will not extend its unconditional cash offer for DTI Group shares, set to close on 29 May 2026, signaling a major governance shake-up and potential delisting.